Structure-guided optimization of 3-hydroxybenzoisoxazole derivatives as inhibitors of Aldo-keto reductase 1C3 (AKR1C3) to target prostate cancer.

MLA

Pippione, Agnese Chiara, et al. “Structure-Guided Optimization of 3-Hydroxybenzoisoxazole Derivatives as Inhibitors of Aldo-Keto Reductase 1C3 (AKR1C3) to Target Prostate Cancer.” European Journal of Medicinal Chemistry, vol. 268, Mar. 2024, p. 116193. EBSCOhost, https://doi.org/10.1016/j.ejmech.2024.116193.

APA

Pippione, A. C., Kovachka, S., Vigato, C., Bertarini, L., Mannella, I., Sainas, S., Rolando, B., Denasio, E., Piercy-Mycock, H., Romalho, L., Salladini, E., Adinolfi, S., Zonari, D., Peraldo-Neia, C., Chiorino, G., Passoni, A., Mirza, O. A., Frydenvang, K., Pors, K., … Boschi, D. (2024). Structure-guided optimization of 3-hydroxybenzoisoxazole derivatives as inhibitors of Aldo-keto reductase 1C3 (AKR1C3) to target prostate cancer. European Journal of Medicinal Chemistry, 268, 116193. https://doi.org/10.1016/j.ejmech.2024.116193

Chicago

Pippione, Agnese Chiara, Sandra Kovachka, Chiara Vigato, Laura Bertarini, Iole Mannella, Stefano Sainas, Barbara Rolando, et al. 2024. “Structure-Guided Optimization of 3-Hydroxybenzoisoxazole Derivatives as Inhibitors of Aldo-Keto Reductase 1C3 (AKR1C3) to Target Prostate Cancer.” European Journal of Medicinal Chemistry 268 (March): 116193. doi:10.1016/j.ejmech.2024.116193.